Mechanism of Disease: Immunoglobulin A Nephropathy
Assessing AKI Risk: Best Practices for Biomarker Testing
Partial Response in Major Depressive Disorder Treatment: Are We Doing Enough?
Unveiling the Numerous Benefits of RTA Prefilled Syringes
Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Advancements in Pretreated Metastatic Triple-Negative Breast Cancer
Addressing Unresolved Symptoms of Major Depressive Disorder
Unraveling the Role of Adjuvanted Flu Vaccines for Older High-Risk Patients
Stephen I. Pelton, MD
PeerMaximizing Flu Protection: The Clinical Value of Cell-Based Vaccines
How to Take a Proactive Approach to AKI Risk Assessment and Management
How to Integrate AKI Risk Assessments into Clinical Workflows
Natalia Castillo Almeida, MD
PeerWhat One Couple Learned Travelling the World with Locum Tenens
How to Recognize & Manage an Angry Patient
Preventing HIV & Substance Use in Incarcerated Women: Can an App Help?
Renuka Jain, MD
PeerNavigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
PTSD Unmet Needs: A Lens on Burden, Impact, and Treatment Challenges
Treating Anti-AChR Antibody Positive gMG: Clinical Trials for 2 Treatment Options
Tuan H. Vu, MD
PeerExamining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerCholangiocarcinoma: Treatment with Targeted Therapies
Understanding the Key Role of FcRn in Anti-AChR Antibody Positive gMG
Nicholas J. Silvestri, MD, FAAN
Peer